Exscientia plc (NASDAQ:EXAI – Get Rating)’s stock price traded down 4.5% during mid-day trading on Friday . The company traded as low as $5.57 and last traded at $5.68. 107,689 shares changed hands during mid-day trading, a decline of 67% from the average session volume of 329,902 shares. The stock had previously closed at $5.95. […]
Exscientia (NASDAQ:EXAI – Get Rating) had its price objective reduced by Morgan Stanley from $15.00 to $14.00 in a research note issued to investors on Monday, Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock. Exscientia Stock Up 7.0 % Shares of NASDAQ:EXAI opened at $5.68 on Monday. The company has […]
Exscientia (NASDAQ:EXAI – Get Rating) had its target price trimmed by Morgan Stanley from $15.00 to $14.00 in a report released on Monday, Benzinga reports. The firm currently has an equal weight rating on the stock. Exscientia Stock Performance NASDAQ EXAI opened at $5.31 on Monday. Exscientia has a twelve month low of $4.09 and […]
Exscientia (NASDAQ:EXAI – Get Rating) and X4 Pharmaceuticals (NASDAQ:XFOR – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk. Analyst Recommendations This is a breakdown of current recommendations and […]
Exscientia plc (NASDAQ:EXAI – Get Rating) shares shot up 3.2% during trading on Wednesday . The stock traded as high as $5.20 and last traded at $5.20. 8,853 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 289,077 shares. The stock had previously closed at $5.04. Exscientia Stock […]